Published in
American Society of Hematology, Blood Advances, 20(3), p. 3013-3019, 2019
DOI: 10.1182/bloodadvances.2019000453
Links
Tools
Pegylated interferon-2α invokes graft-versus-leukemia effects in patients relapsing after allogeneic stem cell transplantation
Journal article published in 2019 by
Andrea S. Henden 
,
Antiopi Varelias ,
Justine Leach,
Elise Sturgeon,
Judy Avery,
Jessica Kelly,
Stuart Olver,
Luke Samson,
Gunter Hartel ,
Simon Durrant,
Jason Butler,
Anthony J. Morton,
Ashish Misra,
Siok-Keen Tey ,
Elango Subramoniapillai
and other authors.
,
Antiopi Varelias ,
Justine Leach,
Elise Sturgeon,
Judy Avery,
Jessica Kelly,
Stuart Olver,
Luke Samson,
Gunter Hartel ,
Simon Durrant,
Jason Butler,
Anthony J. Morton,
Ashish Misra,
Siok-Keen Tey ,
Elango Subramoniapillai
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 
Abstract
Key Points Peg-IFNα is tolerated and induces disease response in patients who relapse after allogeneic SCT. Increased pretreatment MAIT and pDC proportions were associated with better progression-free and overall survival after peg-IFNα treatment.